5-Hydroxybenzofurazan, 97%, 1g

(2-(Ethylthio)-5-(trifluoromethyl)pyridin-3-yl)boronic acid, 95.0%, 1g

3-Fluoro-5-(trifluoromethyl)pyridine, 98.0%, 1g

3-Chloroisoquinolin-1(2H)-one, 98%, 5g

(4S,4aR,5S,5aR,6R,12aS)-4-(Dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide hydrochloride, 98.0%, 1g

Ethyl 4-formylthiazole-5-carboxylate, 95%, 1g

4-[(Diethylcarbamoyl)oxy]benzoic acid, 95.0%, 500mg

(5-bromo-3-methyl-1H-indol-2-yl)methanol, 95.0%, 1g

Methyl (5S,8S,11S)-11-(2-fluoroacetyl)-5-isopropyl-8-methyl-3,6,9-trioxo-1-phenyl-2-oxa-4,7,10-triazatridecan-13-oate, 98%, 10mg

N-(2-Amino-4-trifluoromethylphenyl)pyrrolidine, 97.0%, 5g

(9H-fluoren-9-yl)methyl N-(2-((4-(4-(3-bromo-4-fluorophenyl)-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-1,2,5-oxadiazol-3-yl)amino)ethyl)sulfamoylcarbamate, 98%, 500mg

4-Chloro-5-iodo-1H-indazole, 97%, 100mg

Colonne capillaire GC ROTI®Cap-1701 MS, 30 m, 0,32 mm, 0,50 µm, 1 pièce(s)